Aptus Pharma closes trading window ahead of Q2FY27 results
- Trading window closed from October 1, 2026
- Window reopens 48 hours after Q2FY27 results declaration
- Closure applies to half year ended September 30, 2026
- Notice filed with BSE on September 28, 2026
*this image is generated using AI for illustrative purposes only.
Aptus Pharma Limited has closed its trading window for dealing in company securities starting October 1, 2026. The closure remains in effect until the completion of 48 hours after the declaration of financial results for the half year ended September 30, 2026.
Insider Trading Compliance
The decision is made pursuant to the Company's Code of Conduct for Prohibition of Insider Trading. This measure ensures compliance with regulatory standards regarding the handling of unpublished price-sensitive information during the period leading up to the earnings announcement.
Key Details of Closure
| Parameter | Detail |
|---|---|
| Start Date | October 1, 2026 |
| End Condition | 48 hours after results declaration |
| Reporting Period | Half year ended September 30, 2026 |
| Signatory | Tejash Hathi, Managing Director |
The notice was submitted to The BSE Ltd on September 28, 2026. The Managing Director, Tejash Hathi, signed the communication digitally to inform the exchange of the window closure. This procedural step restricts designated persons from trading in the company's shares during the blackout period to prevent potential misuse of confidential financial data.
Historical Stock Returns for Aptus Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.99% | +0.14% | +17.07% | +153.29% | +942.72% | +942.72% |
How might the upcoming half-year financial results influence Aptus Pharma's stock volatility once the trading window reopens?
What are the potential market reactions if Aptus Pharma reports earnings that significantly deviate from analyst consensus estimates?
Could the timing of this window closure coincide with broader sector-wide earnings announcements, affecting comparative stock performance?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
